Cbl-b-IN-17

• UNSPSC Description:

  Cbl-b-IN-17 (Example-40) is an inhibitor of Cbl-b with an IC50 value [1].

• Target Antigen:

  E1/E2/E3 Enzyme

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/cbl-b-in-17.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1N(C2=CC=CC(C(C3CCC3)C4=NN=CN4C)=C2)C=NC5=C1C=C(CNCC(C)C)C=C5C(F)(F)F

• Molecular Weight:

  524.58

• References & Citations:

  [1]Murugan CHINNAPATTU, et al. Bicyclic heterocyclic compounds as cbl-b inhibitors. WO2024062363A1. 2024-03-28.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported